Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Randomized Clinical Evaluation of the Healing Activity of Green Propolis Ointment in Individuals with Lower Limb Ulcers Resulting from Leprosy: Preliminary Results of a Pilot Study

Rosa CD, Maquedano LK, Bueno IL, et al. MDPI AG. Pharmaceuticals. 2024; 17 (12) : 1-12.
Download PDF
Publication

Tracing Leprosy: The paleopathological study of the individuals excavated from the Sant Llàtzer leprosarium in Barcelona, Spain (12th-18th c.)

Montes N, Jáuregui C, Dinarès R, et al. Elsevier BV. International Journal of Paleopathology. 2024;
Download PDF
Publication

Electrochemical magneto-immunoassay based on Mycobacterium leprae mimotope for serological diagnosis of leprosy

de Almeida SV, da Silva PRL, Fonseca WT, et al. Elsevier BV. Biosensors and Bioelectronics. 2024;
Publication

Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal

Banstola NL, Hasker E, Mieras L, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2024; 18 (12) : 1-15.
Download PDF
Publication

Secular trends in leprosy burden: Comparative insights from India and Brazil in the last three decades using the Global Burden of Disease study data

Shalini , Jha RP, Dhamnetiya D, et al. Lepra. Leprosy Review. 2024;
Download PDF
Publication

Risk factors for leprosy: a systematic review

Pertiwi ANAM, Syahrul F. The Indonesian Journal of Public Health. 2024;
Download PDF
Publication

Rapid test for Mycobacterium leprae infection: a practical tool for leprosy

Pierneef L, van Hooij A, de Jong D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2024; 13 (1) : 1-12.
Download PDF
Publication

Transitions experienced by people living with limitations resulting from leprosy: a research-care study.

Costa R, Fernandes M, Zagonel I. Revista brasileira de enfermagem. 2024; 77 (5) : 1-8.
Download PDF
Publication

Prevalence of paucibacillary cases of leprosy in Brazil: a 20-year systematic review and meta-analysis.

Gonçalves B, Raiol A, Brito A, et al. Frontiers in medicine. 2024;
Download PDF
Publication

Genomic and Phenotypic Variations Among Thai-53 and Clinical Isolates: Implications for Leprosy Pathogenesis and Research.

Gomes T, da Silva T, Machado E, et al. Pathogens (Basel, Switzerland). 2024; 13 (11) : 1-17.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 39
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD